Recent Finacing
Recent Raise
Apmonia Therapeutics is a Reims-based biotech developing TAX2, a therapeutic candidate targeting solid tumors.
Focus Areas
Recent Investors
Valuation as of 09/18/2025
Total Raised
Funding rounds
Investors
See the team members at Apmonia Therapeutics.
